COVID And Aduhelm On The Agenda At Denver Alzheimer's Meeting
Short Wave
00:00
Exploring the Cognitive Impact of COVID-19 and Aduhelm's Approval
This chapter explores the FDA's contentious approval of Aduhelm for Alzheimer's treatment while highlighting the emerging evidence of COVID-19's effects on brain health. Through nurse Cassandra Hernandez's personal experience, it underscores the potential cognitive implications of the virus and ongoing research efforts in the field.
Play episode from 01:35
Transcript
